Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters

Pieter A. Cohen, Bharathi Avula, Kumar Katragunta, Ikhlas A. Khan

JAMA · 2022 · 16 citations · 3 references

DOIFull text

Open access

Concepts

Abstract

This study examines the frequency of product recalls and the presence of FDA-prohibited drugs in supplements after FDA warning letters.

References

3